Due to the abnormal expression of certain B-cell antigens (such as PAX-5+, CD79a+) by the tumor cells, the initial pathological report incorrectly diagnosed the lesion as “diffuse large B-cell lymphoma”. The gene discussed is CD79A; the disease is diffuse large B-cell lymphoma.